Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug discovery
Biotech
Merck inks $349M biobucks deal to apply AI to tricky targets
Merck has doubled down on its pact with Variational AI, striking a deal worth up to $349 million to work on small molecules against two targets.
Nick Paul Taylor
Sep 23, 2025 7:00am
Japan biotech inks RNA research pact that includes mRNA compounds
Sep 19, 2025 10:49am
Amgen unveils plans for $600M R&D site in California
Sep 2, 2025 11:08am
Biotech founder debuts tool to find microprotein drug targets
Aug 11, 2025 7:00am
GSK plans 'very limited' job cuts for global R&D team
Jul 15, 2025 4:15pm
Revolution taps Iambic's AI models in $25M discovery deal
Jul 9, 2025 11:19am